![]() |
市场调查报告书
商品编码
1734876
2032 年眼睑磨砂膏市场预测:按产品类型、类型、配方、分销管道、应用、最终用户和地区进行的全球分析Eyelid Scrub Market Forecasts to 2032 - Global Analysis By Product Type (Pre-Moistened Scrubs, Spray Scrubs and Dry Pad Scrubs), Type, Formulation, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球眼睑磨砂膏市场预计在 2025 年达到 37 亿美元,到 2032 年将达到 68 亿美元,预测期内的复合年增长率为 9.2%。
眼睑磨砂膏是用于去除眼睑和睫毛根部污垢、细菌和多余油脂的清洁液或湿纸巾。它们有助于保持眼部卫生,预防发炎以及诸如眼睑炎和干眼症等疾病。眼睑磨砂膏通常含有温和的界面活性剂、抗菌剂和舒缓成分,可促进眼部舒适并减轻发炎。定期使用眼睑磨砂膏可以去除引起不适和感染的污染物,从而促进整体眼部健康,确保视力更清晰,眼睑组织更健康。
根据美国美国生物技术资讯中心(NCBI)公布的数据,据报导,美国干眼症的患病人数为2,750万人,英国为2,260万人,德国为1,800万人,澳洲为240万人,印度为4.572亿人。
眼睑炎和干眼症的盛行率不断上升
随着这些眼科疾病在各个人群中日益普遍,对有效的家庭治疗和预防性卫生习惯的需求也在稳步增长。患有眼睑炎和併发症并伴有不适和潜在併发症的人们正在积极寻求眼睑磨砂膏等便捷的解决方案来控制症状并保持眼部健康。盛行率的上升,加上人们对这些疾病的认识不断提高,直接促进了眼睑清洁产品市场的扩张。
消费者知识有限
由于消费者对眼睑清洁的重要性以及这些产品带来的实际益处缺乏了解,市场发展受到阻碍。许多消费者可能并未充分意识到定期清洗眼睑在预防和控制眼睑炎、干眼症等疾病方面所扮演的角色。这种认知不足可能会导致眼睑磨砂膏的普及率较低,市场扩张缓慢,因为消费者可能不会优先购买眼睑磨砂膏,而是优先购买普通的洗面乳或其他护肤品。
天然成分和低过敏性配方的创新
随着消费者越来越偏好选择更温和、更天然的成分,能够提供有效且不含刺激性化学物质和潜在过敏原的眼睑磨砂膏的製造商将拥有竞争优势。这一趋势对于皮肤或眼睛敏感的人尤其重要,因为他们可能一直以来都不愿意使用眼睑清洁产品。满足消费者对较温和、亲肤的产品日益增长的需求,可以帮助企业扩大市场覆盖范围,并提升消费者信任度。
与现有护肤和製药公司的激烈竞争
这些规模较大的公司通常拥有品牌知名度、广泛的分销网络和雄厚的营销预算,这使得眼睑磨砂膏领域的小型公司或新参与企业难以获得市场占有率。消费者已经有了自己偏好的护肤习惯,或依赖医疗保健专业人士推荐的处方药或非处方药,因此他们可能会忽略专注于眼睑卫生的产品。
新冠疫情对眼睑清洁产品市场产生了多方面的影响。一方面,人们对个人卫生和健康意识的提升可能间接提高了人们对眼部护理习惯的关注,并刺激了眼睑清洁产品的需求。另一方面,供应链中断、经济不确定时期消费者在非必需品上的支出减少以及医疗保健重点的转变,都可能对市场成长构成挑战。
预计在预测期内,预湿磨砂膏市场将占据最大份额
喷雾式眼部磨砂膏预计将在预测期内占据最大的市场占有率,因为喷雾式眼部磨砂膏的便利性和易用性使其成为日常眼睑清洁的热门选择。其便携性和预先计量的配方深受寻求快速有效清洁解决方案的忙碌消费者的青睐。
预计在预测期内,有机/天然部分将以最高的复合年增长率成长。
预计有机/天然产品类别将在预测期内实现最高成长率,这得益于消费者对天然和植物来源成分产品的日益偏好,这主要源于消费者对潜在皮肤敏感问题的担忧以及对更健康生活方式的普遍追求。随着消费者积极寻求更清洁、更永续的个人护理选择,对温和有效的有机天然眼睑磨砂膏的需求预计将大幅增长。
预计亚太地区将在预测期内占据最大的市场占有率,这得益于其人口众多、人们对眼部健康问题的认识不断提高、可支配收入不断增加以及医疗保健和个人保健产品供应的日益增加。此外,亚太地区部分地区的环境因素和生活方式的改变导致眼科疾病盛行率上升,这也推动了市场的成长。
在预测期内,北美预计将实现最高的复合年增长率,这得益于该地区对医疗保健和个人健康的日益重视、消费者对眼部健康的高度关注、先进的医疗基础设施和创新产品的普及。此外,北美地区干眼症和眼睑炎的盛行率不断上升,以及积极主动的治疗措施,预计将显着促进市场的快速扩张。
According to Stratistics MRC, the Global Eyelid Scrub Market is accounted for $3.7 billion in 2025 and is expected to reach $6.8 billion by 2032 growing at a CAGR of 9.2% during the forecast period. Eyelid scrub is a cleansing solution or wipe designed to remove debris, bacteria, and excess oils from the eyelids and lash margins. It helps maintain ocular hygiene, preventing irritation and conditions such as blepharitis or dry eye syndrome. Typically formulated with gentle surfactants, antimicrobial agents, or soothing ingredients, eyelid scrubs promote eye comfort and reduce inflammation. Regular use supports overall eye health by eliminating contaminants that can contribute to discomfort or infection, ensuring clearer vision and healthier eyelid tissue.
According to data published by the National Centers for Biotechnology Information (NCBI), it was reported that the prevalence of dry eye disease is 27.5 million in the U.S., 22.6 million in the U.K., 18.0 million in Germany, 2.4 million in Australia, and 457.2 million in India.
Rising prevalence of blepharitis and dry eye syndrome
As these ocular conditions become more prevalent across various demographics, the demand for effective at-home treatments and preventative hygiene practices is steadily increasing. Individuals experiencing the discomfort and potential complications associated with blepharitis and dry eye are actively seeking accessible solutions like eyelid scrubs to manage their symptoms and maintain ocular health. This growing patient pool, coupled with increased awareness of these conditions, directly contributes to the expanding market for eyelid cleansing products.
Limited consumer knowledge
The limited understanding among consumers regarding the importance of eyelid hygiene and the specific benefits offered by these products hamper the market. Many individuals may not be fully aware of the role that regular eyelid cleansing plays in preventing and managing conditions like blepharitis and dry eye. This lack of awareness can result in lower adoption rates and a slower market expansion as consumers might not prioritize the purchase of dedicated eyelid scrubs over general facial cleansers or other skincare products.
Innovation in natural and hypoallergenic formulations
As consumer preferences increasingly lean towards gentler and more natural ingredients, manufacturers who can offer effective eyelid scrubs free from harsh chemicals and potential allergens stand to gain a competitive edge. This trend is especially relevant for individuals with sensitive skin or eyes, who may have previously been hesitant to use conventional eyelid cleansing products. By catering to this growing demand for milder and more skin-friendly options, companies can expand their market reach and foster greater consumer trust.
Intense competition from established skincare and pharmaceutical companies
These large corporations often possess significant brand recognition, extensive distribution networks, and substantial marketing budgets, making it challenging for smaller or newer entrants in the eyelid scrub segment to gain market share. Consumers may already have preferred skincare routines or rely on prescription or over-the-counter medications recommended by healthcare professionals, potentially overlooking specialized eyelid hygiene products.
The COVID-19 pandemic had a multifaceted impact on the Eyelid Scrub market. On one hand, increased focus on personal hygiene and health awareness may have indirectly led to greater attention on eye care routines, potentially boosting demand for eyelid cleansing products. Conversely, disruptions in supply chains, reduced consumer spending on non-essential items during periods of economic uncertainty, and shifts in healthcare priorities could have presented challenges for market growth.
The pre-moistened scrubs segment is expected to be the largest during the forecast period
The pre-moistened scrubs segment is expected to account for the largest market share during the forecast period attributed to the convenience and ease of use offered by pre-soaked wipes, making them a popular choice for daily eyelid hygiene. Their portability and pre-measured formulation resonate well with busy consumers seeking a quick and effective cleansing solution.
The organic/natural segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the organic/natural segment is predicted to witness the highest growth rate due to rapid growth reflects the increasing consumer preference for products formulated with natural and plant-derived ingredients, driven by concerns about potential skin sensitivities and a general inclination towards healthier lifestyles. The demand for gentle yet effective organic and natural eyelid scrubs is expected to surge as consumers actively seek out cleaner and more sustainable personal care options.
During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to the region's large population base, rising awareness of eye health issues, increasing disposable incomes, and growing accessibility to healthcare and personal care products. Furthermore, environmental factors and lifestyle changes contributing to a higher prevalence of eye conditions in certain parts of Asia Pacific are also likely to fuel market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by a strong emphasis on healthcare and personal wellness, high consumer awareness of eye health, and the presence of advanced healthcare infrastructure and innovative product offerings. Additionally, the increasing prevalence of dry eye disease and blepharitis in North America, coupled with proactive approaches to managing these conditions, is expected to contribute significantly to the market's rapid expansion.
Key players in the market
Some of the key players in Eyelid Scrub Market include Visine, TheraTears, Thea Pharmaceuticals, Systane, Scope Ophthalmics, Optase, OCuSOFT, NovaBay Pharmaceuticals, Lumenis, Johnson & Johnson Vision, Heyedrate, Cliradex, Bruder Healthcare, Blephadex, Bausch + Lomb, Avenova and Akorn Pharmaceuticals.
In April 2025, Lumenis announced the expansion of its FoLix(TM) fractional laser treatment for hair loss into the Canadian market. The product, which is FDA and Health Canada-cleared, was also named 'Best Laser Treatment for Hair Loss' by NewBeauty's 15th Annual Beauty Awards.
In February 2025, Cliradex announced the reformulation of its natural eyelid towelettes to enhance efficacy against Demodex mites, a common cause of blepharitis. The new formulation aims to provide improved relief for patients suffering from ocular irritation.
In January 2025, Heyedrate launched a new eyelid and facial cleanser formulated with organic ingredients to provide relief for dry, itchy eyes and skin conditions like blepharitis and rosacea. The product is designed to be gentle yet effective, catering to individuals with sensitive skin.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.